Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nianxiang Zhang
Affiliation
ORCID
Career Start Year
2000
Papers
78
H Index
37
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35199472
Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015.
Cancer Med
2022
36274734
The Zinc-Finger protein ZCCHC3 inhibits LINE-1 retrotransposition.
Frontiers in Microbiology
2022
35685648
A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique.
Frontiers in Pharmacology
2022
35982398
The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma.
BMC Cancer
2022
34430717
Factors associated with complex oral treatment device usage in patients with head and neck cancer.
Clin Transl Radiat Oncol
2021
34332039
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.
Cancer Letters
2021
33596096
Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer.
JCO Oncol Pract
2021
33293428
-Mediated Regulation of mA-Modified by mA Reader IGF2BP3 Drives ccRCC Progression.
Cancer Research
2021
34659550
MIR-4507 Targets to Facilitate the Malignant Progression of Non-small-cell Lung Cancer.
Journal of Cancer
2021
30788162
Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis.
J Gastrointest Oncol
2019
30876488
How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.
Gynecol Oncol
2019
29140558
Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Cancer
2018
31773031
Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer.
Int J Part Ther
2018
30092967
Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
JACC Cardiovasc Imaging
2018
28185526
Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
Leuk Lymphoma
2017
28388292
End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.
J Clin Oncol
2017
28270436
Focal Adhesion Kinase as a Potential Target in AML and MDS.
Mol Cancer Ther
2017
27885271
p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status.
Leukemia
2017
26716915
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
Cancer
2016
25248926
Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia.
Clin Lymphoma Myeloma Leuk
2015
25541150
Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.
Leukemia
2015
25964256
Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer.
J Clin Oncol
2015
25380958
Development of a robust classifier for quality control of reverse-phase protein arrays.
Bioinformatics
2015
26058080
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia.
Cancer Cell
2015
26073130
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
Cancer Cell
2015
26674329
Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients.
BBA Clin
2015
26711339
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199.
Cell Rep
2015
24858343
The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.
Biochim Biophys Acta
2014
24248418
Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.
Digestive Diseases and Sciences
2014
24414704
Age-related epigenetic drift in the pathogenesis of MDS and AML.
Genome Res
2014
24868022
Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer.
J Clin Oncol
2014
23576428
Transglutaminase 2 expression in acute myeloid leukemia: association with adhesion molecule expression and leukemic blast motility.
Proteomics
2013
22886728
Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.
Mol Imaging Biol
2013
24223100
Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.
PLoS One
2013
24149137
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.
Oncologist
2013
24127446
Trastuzumab-related cardiotoxicity among older patients with breast cancer.
J Clin Oncol
2013
23564911
Prognostic impact and targeting of CRM1 in acute myeloid leukemia.
Blood
2013
23634996
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
N Engl J Med
2013
23257362
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.
J Clin Invest
2013
23583282
Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.
Am J Pathol
2013
21653683
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.
Annals of Oncology
2012
22893484
Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells.
Ann Hematol
2012
22645176
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.
Blood
2012
22581181
SRMA: an R package for resequencing array data analysis.
Bioinformatics
2012
22415601
Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma.
Cancer
2012
22371383
Anthracycline regimen adherence in older patients with early breast cancer.
Oncologist
2012
22311693
Cancer prevention health services research: an emerging field.
Journal of Cancer Education
2012
23259068
PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells.
Leuk Res Treatment
2012
21858090
Mechanisms of resistance to decitabine in the myelodysplastic syndrome.
PLoS One
2011
21393379
Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.
Ann Oncol
2011
1 - 50 of 78
Column Actions
Search
Recommended Authors
Collaborators
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers
24
Kevin R Coombes
Medical College of Georgia
Co-authored papers
20
Sharon H Giordano
The University of Texas MD Anderson Cancer Center
Co-authored papers
15
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers
6
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers
5
Thomas A Buchholz
Co-authored papers
5
Linda S Elting
Co-authored papers
4
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Jean-Pierre J Issa
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Co-authored papers
4
Jorge Cortes
Georgia Cancer Center
Co-authored papers
4
Steven H Lin
University of Texas MD Anderson Cancer Center
Co-authored papers
3
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Benjamin D Smith
Co-authored papers
3
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Co-authored papers
3
Amina A Qutub
University of Texas at San Antonio
Co-authored papers
3
Gautam Borthakur
MD Anderson Cancer Center
Co-authored papers
3
Shoudan Liang
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Takae Kiyama
University of Texas Health Science Center at Houston Medical School
Co-authored papers
3
William H Klein
Columbia University
Co-authored papers
3
Shuguang Liang
The University of Texas M. D. Anderson Cancer Center
Co-authored papers
3
Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers
2
Suja S Rajan
UTHealth School of Public Health
Co-authored papers
2
Carrie Sougnez
The Broad Institute of Harvard and MIT
Co-authored papers
2
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers
2
Christopher I Amos
Baylor College of Medicine
Co-authored papers
2
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers
2
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers
2
Wenyi Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
2
1 - 30